Lindenane sesquiterpenoid dimers with NLRP3 inflammasome inhibitory activities from Chloranthus holostegius var. shimianensis - 23/07/24
Abstract |
Thirteen previously undescribed lindenane sesquiterpenoid dimers (LSDs), named chlorahololides G–S (1–13), were isolated from the whole plants of Chloranthus holostegius var. shimianensis, along with ten known analogues (14–23). The structures and absolute configurations of compounds 1–13 were elucidated through comprehensive spectroscopic analysis, NMR and electronic circular dichroism (ECD) calculations, and X-ray single-crystal diffraction. Chlorahololide G (1) represents the first instance of LSDs formed via a C-15–C-9′ carbon-carbon single bond, whose plausible biosynthetic pathway was also proposed. Chlorahololides I and J (3 and 4) were deduced to be rare 8,9-seco and 9-deoxy LSDs with C-11–C-7′ carbon-carbon bond, respectively. The inhibitory activity against NLRP3 inflammasome activation was evaluated for all isolates, with six compounds (5, 7, 8, 17, 22, and 23) exhibiting significant effects, and IC50 values ranging from 2.99 to 8.73 µM. Additionally, a preliminary structure-activity relationship analysis regarding their inhibition of NLRP3 inflammasome activation was summarized. Compound 17 exhibited dose-dependent inhibition of nigericin-induced pyroptosis in J774A.1 cells. Molecular docking studies suggested a strong interaction between compound 17 and NLRP3.
Le texte complet de cet article est disponible en PDF.Graphical Abstract |
Highlights |
• | Twenty-three sesquiterpenoid dimers are isolated from C. holostegius var. shimianensis. |
• | Compounds 1, 3, and 4 are lindenane sesquiterpenoid dimers with novel structures. |
• | Six compounds show significant inhibitory effect on NLRP3 inflammasome activation. |
• | Compound 17 exhibits a dose-dependent inhibition on pyroptosis in J774A.1 cells. |
• | Compound 17 shows a strong binding with NLRP3 in a molecular docking study. |
Keywords : Chloranthus holostegius var. shimianensis, Lindenane sesquiterpenoid dimers, Chlorahololides G–S, NLRP3 inflammasome inhibition, Pyroptosis
Plan
Vol 177
Article 117087- août 2024 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?